Simply a quick reminder for those interested to pre-register for the IPD Investor conference call on Monday morning.
ImpediMed Quarterly Results and Investor Conference Call Notification:
ImpediMed Limited (ImpediMed or the Company) (ASX:IPD) advises it will release its Appendix 4C Cash Flow Statement and Quarterly Results for the period ending 31 March 2023, on Monday 17th April 2023.
Investors are invited to join a live conference call and Q&A hosted by Managing Director and CEO, Rick Valencia at 9.30am (AEST) on Monday 17th April 2023.
To pre-register, please follow this link: https://s1.c-conf.com/diamondpass/10029861-svnw7h.html Registered participants will receive a calendar notification with dial in details and a PIN for fast-track access to the call.
Approved for release by the Managing Director and CEO, Mr Rick Valencia.